Through the service, physicians will be able to send a patient’s tumor tissue to Quest Diagnostics for genetic sequencing. IBM Watson will then analyze the genetic alterations in the tissue, and Memorial Sloan Kettering will conduct a research-based analysis through its oncology precision medicine database to determine potential treatment options.
Through the collaboration, the partners hope to give physicians “the ability to create a unique, personalized approach for their patients,” according to IBM.
More articles on health IT:
USAID funds technology platform to identify Zika “cold spots” in Guatemala
Eastern Oklahoma VA, local healthcare organizations to share veteran health information through eHealth Exchange
Mobile health app revenue expected to grow through 2020: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
